Literature DB >> 25731412

Clinical analysis of esophageal cancer patients with a history of metachronous primary cancer.

Michihiro Kudou1, Atsushi Shiozaki, Hitoshi Fujiwara, Toshiyuki Kosuga, Hirotaka Konishi, Ryo Morimura, Yasutoshi Murayama, Shuhei Komatsu, Yoshiaki Kuriu, Hisashi Ikoma, Masayoshi Nakanishi, Daisuke Ichikawa, Kazuma Okamoto, Chouhei Sakakura, Eigo Otsuji.   

Abstract

Esophageal cancer (EC) is often associated with multiple primary cancers, and the frequency of EC in patients with a history of metachronous primary cancers (HMPC) was reported as 7.8%. The clinical characteristics of these cases have not yet been elucidated in detail. Therefore, we analyzed 36 EC patients with HMPC among 370 cases that underwent curative resection in our hospital between 1996 and 2013. The most frequent HMPC was gastric cancer (36.1%). The group with HMPC was significantly older than the group without HMPC, whereas no significant differences were observed in other background factors. The stomach was used for reconstruction more frequently reconstructed in the group without HMPC (p<.05). No significant differences were observed in surgical complications between the 2 groups (p=0.283). The 5-year overall survival rates were similar between the groups. The safety of surgery for and prognosis of EC patients with HMPC were similar to those of EC patients without HMPC; therefore, curative surgery should be considered for EC patients with HMPC.

Entities:  

Mesh:

Year:  2014        PMID: 25731412

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  4 in total

1.  Short- and long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell cancer in patients with prior gastrectomy.

Authors:  Jia-Qi Xu; Jian-Wei Hu; Wei-Feng Chen; Mei-Dong Xu; Yun-Shi Zhong; Shi-Yao Chen; Yi-Qun Zhang; Li-Li Ma; Wen-Zheng Qin; Ming-Yan Cai; Li-Qing Yao; Ping-Hong Zhou; Quan-Lin Li
Journal:  Surg Endosc       Date:  2020-05-19       Impact factor: 4.584

2.  Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancer.

Authors:  Rieko Nakamura; Tai Omori; Hiroya Takeuchi; Hirofumi Kawakubo; Tsunehiro Takahashi; Norihito Wada; Yoshiro Saikawa; Yuko Kitagawa
Journal:  Oncol Lett       Date:  2016-04-20       Impact factor: 2.967

3.  Curative resection of advanced esophageal cancer with metachronous stage IV breast cancer: A case report.

Authors:  Yusuke Gokon; Tadashi Sakurai; Fumiyoshi Fujishima; Yusuke Taniyama; Takahiro Heishi; Hiroshi Okamoto; Shota Maruyama; Hirotaka Ishida; Yu Onodera; Hironobu Sasano; Takashi Kamei
Journal:  Int J Surg Case Rep       Date:  2018-03-19

4.  Clinicopathological features and prognosis of patients with esophageal cancer as the second primary cancer: a large population-based analysis using the SEER program [2000-2015].

Authors:  Zhencong Chen; Ming Li; Ke Ma; Zhengyang Hu; Shuai Wang; Hongyu Chen; Yuansheng Zheng; Cheng Zhan; Zongwu Lin; Qun Wang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.